Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China SXT Pharmaceuticals ( (SXTC) ) just unveiled an update.
On May 5, 2025, China SXT Pharmaceuticals entered into a securities purchase agreement with an investor to sell 200,000 Ordinary Shares, generating approximately $100,000 in gross proceeds. The transaction was completed on May 12, 2025, increasing the total outstanding shares to 16,027,758. This move is part of the company’s strategy to raise capital, potentially impacting its financial position and market operations.
More about China SXT Pharmaceuticals
China SXT Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on the development and sale of traditional Chinese medicine products. The company is based in Taizhou, Jiangsu, China, and is involved in the production of various medicinal products aimed at addressing a range of health conditions.
Average Trading Volume: 4,103,822
Technical Sentiment Signal: Sell
Current Market Cap: $33.66M
For a thorough assessment of SXTC stock, go to TipRanks’ Stock Analysis page.